Nobivac® Lyme

Video: How ticks transmit disease to dogs…

Video: How do you know if a vaccine is protecting your patients from Lyme disease...

Nobivac^® Lyme is a bacterin that contains two inactivated strains of Borrelia burgdorferi comprised of outer surface protein A (OspA) and outer surface protein C (OspC). It is adjuvanted to elicit an immune response. This bacterin is approved for the vaccination of healthy dogs as an aid in the prevention of subclinical arthritis caused by B. burgdorferi.

Nobivac^® Lyme is administered subcutaneously as an initial vaccination followed by a booster 2 to 4 weeks later. It can be given to dogs beginning at 8 weeks of age. Annual re-vaccination with Nobivac^® Lyme is recommended.

*Nobivac^® Lyme aids in the prevention of subclinical arthritis caused by Borrelia burgdorferi.